-

Azitra to Present at the Upcoming 2020 Summer Private Company Showcase

BRANFORD, Conn.--(BUSINESS WIRE)--Azitra, Inc., a clinical-stage medical dermatology biotech company addressing serious skin conditions by harnessing the microbiome, today announced that Richard Andrews, President and Chief Executive Officer, is scheduled to present an overview of the company at the upcoming Summer Private Company Showcase 2020 hosted by Solebury Trout, Piper Sandler and White & Case. During the 20-minute presentation, participants will be able to submit questions electronically with answers provided at the discretion of the company on an individual basis afterwards.

Details for the presentation are as follows:

Date: August 10, 2020

Time: 12:20 pm PST

Registration: https://troutaccess.com/index.php/c/Summer2020PCS

An archive of the event will be available through the Azitra website.

About Azitra
Azitra, Inc. is a clinical-stage medical dermatology company that combines the power of the microbiome with cutting-edge genetic engineering to treat skin disease. The company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its pharmaceutical and consumer product programs to treat therapeutic needs including cancer therapy-associated skin rashes, Netherton syndrome and atopic dermatitis as well as skin appearance. Learn more at www.azitrainc.com

Contacts

Michelle Linn
Bioscribe, Inc.
774-696-3803
michelle@bioscribe.com

Azitra, Inc.


Release Summary
Richard Andrews, President and CEO, is scheduled to present an overview of the company at the upcoming Summer Private Company Showcase
Release Versions

Contacts

Michelle Linn
Bioscribe, Inc.
774-696-3803
michelle@bioscribe.com

More News From Azitra, Inc.

Azitra Appoints Francisco Salva as Chief Executive Officer

BRANFORD, Conn.--(BUSINESS WIRE)--Francisco Salva brings a proven dedication to building companies to Azitra....

Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra

LEVERKUSEN, Germany & BRANFORD, Conn.--(BUSINESS WIRE)--Azitra completes USD 17 million Series B financing led by Leaps by Bayer...

Azitra Awarded U.S. Composition of Matter Patent Covering Engineered Bacterial Strains for Treating Skin Conditions

FARMINGTON, Conn.--(BUSINESS WIRE)--Azitra receives broad composition of matter patent covering core technology and publishes data in mSphere...
Back to Newsroom